BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
-7.93%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$483M
AUM Growth
+$483M
(-19%)
Cap. Flow
-$45.9M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
4
Reduced
1
Closed
–
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$18.8M |
| 2 |
STAAR Surgical
STAA
|
$13.1M |
| 3 |
IMPR
IMPRIVATA, INC COM
IMPR
|
$876K |
| 4 |
Lineage Cell Therapeutics
LCTX
|
$861K |
Top Sells
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$79.5M |
Sector Composition
| 1 | Consumer Staples | 44.19% |
| 2 | Healthcare | 35.87% |
| 3 | Technology | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$60.9B
| $213M | 44.19% | 1,599,136 | – | – |
|
|
2
STAAR Surgical
STAA
$1.36B
| $77M | 15.95% | 10,417,670 +1,770,747 | +20% | +$13.1M |
|
|
3
Lineage Cell Therapeutics
LCTX
$267M
| $63.6M | 13.18% | 22,164,396 +300,000 | +1% | +$861K |
|
|
4
iShares Russell 2000 ETF
IWM
$67B
| $46.5M | 9.63% | 420,000 +170,000 | +68% | +$18.8M |
|
|
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
| $40.5M | 8.38% | 916,975 | – | – |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $19.8M | 4.09% | 322,411 -1,297,557 | -80% | -$79.5M |
|
|
IMPR
7
DELISTED
IMPRIVATA, INC COM
IMPR
| $9.32M | 1.93% | 737,911 +69,385 | +10% | +$876K |
|
|
AST
8
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $7.71M | 1.6% | 1,641,025 | – | – |
|
|
IMDX
9
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $5.04M | 1.04% | 1,093,219 | – | – |
|